🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Neutropenic Fever

The Ambient Light Multiple Myeloma Study NCT05737732NA2 sites📍 New York📍 New York Icahn School of Medicine at Mount Sinai · Tests: Circadian Effective Lighting, Circadian Ineffective Lightning (CIL) Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients. NCT07204522n/a1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Carbapenems, Anti-Gram-positive agent, Antifungal agent, Ceftazidime-avibactam + Aztreonam Next-Generation-Sequencing Approach to Neutropenic Sepsis NCT05815628n/a6 sites📍 Cologne📍 Dessau📍 Essen Boris Böll · Tests: DISQVER Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever NCT04270786NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Early de-escalation, Standard Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens NCT06342115Phase 41 site📍 São Paulo Beneficência Portuguesa de São Paulo · Tests: Ceftolozane-Tazobactam, Meropenem Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients NCT07372131NA1 site📍 Rozzano Valeria Cento · Tests: Clinical Stability-Driven Antibiotic Discontinuation Strategy, Standard of Care Antibiotic Duration Phase II Study of QLC2519 in Pediatric Solid Tumor Participants NCT07724756Phase 21 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: Albipagrastim alf Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia NCT07277387n/a3 sites📍 Barcelona📍 Salamanca📍 Seville Instituto de Investigación Biomédica de Salamanca · Tests: Plasma and DNA sample collection for proteomic and genomic analysis Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN NCT07187908Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Efbemalenograstim alfa Injection Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever NCT07051525NA2 sites📍 Melbourne📍 Melbourne Peter MacCallum Cancer Centre, Australia · Tests: Early antibiotic cessation alert Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies NCT07016165Phase 41 site📍 Sleman Gadjah Mada University · Tests: Ceftazidime, Ciprofloxacin Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy NCT07205536Phase 21 site📍 Nantong Affiliated Hospital of Nantong University · Tests: Mecapegfilgrastim injection, Oral or short-acting granulocyte-stimulating agents
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy